Phase1 randomized placebo-controlled double blind dose-escalation study of safety tolerability pharmacokinetics pharmacodynamics & immunogenicity of intravenous dose PF-04360365 (RN119) - altzheimers (2007–2009)

Grant type:
Pfizer Pty Ltd
Researchers:
  • Professor
    Royal Brisbane Clinical Unit
    Faculty of Medicine
    Affiliate Professor
    UQ Centre for Clinical Research
    Faculty of Medicine
Funded by:
Pfizer Pty Ltd